Jean-Pierre Lecocq

This inventor holds 10 USPTO granted patents. Top assignees: Transgene S.a., Institut Pasteur, Transgene S.a. and Institute Pasteur. Active years: 1992-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Lecocq. Retrieved from https://idiyas.com/inventor/jean-pierre-lecocq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 71(Granted Patents)

Location History:

Reichstett, FR (1992 - 1998)
Reichsteet, FR (1998 - 2000)

Company Filing History:

Transgene S.a. and Institute Pasteur

patent

4. 1 out of 1

Transgene S.a., Institut Pasteur

patent

where one patent can have more than one assignee

Years Active: 1992-2000

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6072029 - Derivatives of human .alpha..sub.1 -antitrypsin and process for their (2000-06-06),

2. 6024953 - Vaccine against rabies and process for preparation thereof (2000-02-15),

3. 5830477 - Vaccine against rabies and process for preparation thereof (1998-11-03),

4. 5824505 - Vectors, transformed cells and process for the preparation of hirudin (1998-10-20),

5. 5821079 - Vectors for the expression and secretion of hirudin by transformed yeasts (1998-10-13),

6. 5795577 - Viral vector coding for a glycoprotein of the virus responsible for (1998-08-18),

7. 5705355 - Hirudin, pharmaceutical compositions comprising it and their use (1998-01-06),

8. 5672689 - Non-cleavable GP160 glycoproteins of HIV (1997-09-30),

9. 5597570 - Protein recognized by antibodies raised against native P28 of (1997-01-28),

10. 5169763 - Viral vector coding glycoprotein of HIV-1 (1992-12-08),

Title: Innovations of Jean-Pierre Lecocq

Introduction

Jean-Pierre Lecocq is a notable inventor based in Reichsteet, France. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins and vaccines. With a total of 10 patents, Lecocq's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Lecocq has developed derivatives of human α1-antitrypsin. This invention relates to an analog of human α1-antitrypsin characterized by specific amino acid modifications. Another significant patent involves a vaccine against rabies, which utilizes a vaccinia virus containing a DNA sequence coding for an antigenic glycoprotein of rabies. These innovations showcase his expertise in protein engineering and vaccine development.

Career Highlights

Throughout his career, Lecocq has worked with prominent organizations such as Transgene S.A. and Institut Pasteur. His work in these institutions has allowed him to collaborate with leading scientists and contribute to groundbreaking research in the field of immunology and therapeutic development.

Collaborations

Some of his notable coworkers include Marie-Paule Kieny and Guy Rautmann. Their collaborative efforts have further advanced the research and development of innovative medical solutions.

Conclusion

Jean-Pierre Lecocq's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in medical science and therapeutic applications.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]